Lymphoma Trials

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma   OPEN COHORTS: MANTLE CELL, FOLICULAR LYMPHOMA, Marginal Zone

A phase I/II study of BTCT4465A in patients who do not achieve CR to 1L therapy for DLBCL and as 1L therapy for patients unfit to receive full-dose anthracycline-based chemotherapy Regulatory Packet sent to Sponsor.

A Phase 1 Study of TG-1501 in Subjects with Relapsed or Refractory Lymphoma

A Phase 1 a/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients with CLL/SLL or Non-Hodgkin’s Lymphomas